Parkinson Disease 6, Early-Onset: Clinical Trials

3 trials for Parkinson Disease 6, Early-Onset, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 not yet recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1
Phase 31Not yet recruiting 1

Follow Parkinson Disease 6, Early-Onset: new trials by email Literature Review of Parkinson Disease 6, Early-Onset trials Research Report on Parkinson Disease 6, Early-Onset

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease
TJ0113 200mg, TJ0113 400mg, Placebo - Parkinson's Disease (PD), Parkinson Disease 6, Early-Onset
Phase 3Not yet recruitingHangzhou PhecdaMed Co., Ltd.3002026-08-032026-08-12
A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease
Placebo, ACI-7104.056 at Dose A, ACI-7104.056 at Dose B (optional) - Parkinson Disease, Parkinson Disease 6, Early-Onset
Phase 2Active not recruitingAC Immune SA1502023-07-242026-10-01
Hereditary Parkinson s Disease Natural History Protocol
Parkinson Disease 6, Early-Onset, Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human
CompletedNational Heart, Lung, and Blood Institute (NHLBI)312015-07-082026-10-13

Narrower conditions

Parkinson Disease (3)  ·  Parkinson Disease 6, Autosomal Recessive Early-Onset (3)  ·  Neuroinflammatory Diseases (1)  ·  Parkinsonian Disorders (1)

Broader conditions

Basal Ganglia Diseases (3)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Movement Disorders (3)  ·  Nervous System Diseases (3)  ·  Neurodegenerative Diseases (3)  ·  Synucleinopathies (3)  ·  Parkinsonian Disorders (2)  ·  Inflammation (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Sponsors

AC Immune SA (1)  ·  Hangzhou PhecdaMed Co., Ltd. (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)

Countries

China (1)  ·  Germany (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Daniela Berg, Prof. (1)  ·  Derek P Narendra, M.D. (1)

Results publications

PMID 32562684